VIVUS, Inc. (NASDAQ:VVUS)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to the development and commercialization of therapeutic products using patented proprietary formulations and novel delivery systems and by seeking new indications for previously approved pharmaceutical products.

Recs

1
Player Avatar catfacemcgee (< 20) Submitted: 7/15/2010 6:04:51 PM : Underperform Start Price: $5.11 VVUS Score: -360.12

Drug not approved.

Featured Broker Partners


Advertisement